Contrave ER 8-90 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F98YS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,011
Award facts
- Contract value 100% obligated
- $12,011.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,011.09 delivery order to Amerisourcebergen Drug Corp on February 11, 2026, for Contrave ER 8-90 mg tablets (120 count). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026.
Place of performance is Conshohocken, PA 19428. Ultimate completion date is February 12, 2026. The order carries firm fixed pricing with no set-aside.
Quick answers
Who was awarded contract SPE2DR26F98YS?
SPE2DR26F98YS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 11, 2026.
How much is contract SPE2DR26F98YS worth?
The government has obligated $12,011 on SPE2DR26F98YS.
Is contract SPE2DR26F98YS an order under another contract?
Yes. SPE2DR26F98YS is a delivery order under SPE2DR25D7060, an indefinite delivery contract.
Was contract SPE2DR26F98YS competed?
The extent of competition for SPE2DR26F98YS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award